Business
iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference
iOnctura, a clinical-stage biopharmaceutical company developing precision oral small molecules for neglected and hard-to-treat cancers, today announces that its Chief Executive Officer, Catherine Pickering, will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12–15, 2026, in San Francisco, California.
About this update from Jp Morgan Chase & Co.
[{"type":"list","items":[{"val":[{"type":"text","content":"Participation underscores growing excitement around company's momentum and potential in precision oncology","length":110,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":110,"olType":false},{"type":"text","content":"GENEVA, AMSTERDAM and CAMBRIDGE, Mass., Jan. 9, 2026 /PRNewswire/ -- iOnctura, a clinical-stage biopharmaceutical company developing precision oral small molecules for neglected and hard-to-treat cancers, today announces that its Chief Executive Officer, Catherine Pickering, will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12–15, 2026, in San Francisco, California.","length":406,"tagName":"p"},{"type":"image","alt":"iOnctura Logo (PRNewsfoto/iOnctura)","displaySize":"","headline":null,"caption":"iOnctura Logo (PRNewsfoto/iOnctura)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":86,"url":"https://media.zenfs.com/en/prnewswire.com/11972ceeeca0affbf0b2d5da644ab0d1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8xREJtfjvexA07Hd8X8nig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1MjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/11972ceeeca0affbf0b2d5da644ab0d1","width":400,"height":86}},"href":"https://mma.prnewswire.com/media/2736715/iOnctura_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Dr. Pickering will present on Thursday, January 15, 2026 at 11:00 PST. The presentation will highlight iOnctura's clinical progress with a focus on its lead program, roginolisib, the first allosteric modulator of PI3Kδ.","length":223,"tagName":"p"},{"type":"text","content":"Recognized as the world's largest and most influential healthcare investment conference, the J.P. Morgan Healthcare Conference is an invite-only event that serves as a vital forum for innovation and capital formation across the pharmaceutical and biotechnology sectors. Participation reflects iOnctura's growing visibility within the global oncology ecosystem and underscores the company's progress towards advancing transformative targeted therapies for patients with cancer.","length":488,"tagName":"p"},{"type":"text","content":""We are honored to be invited to present at this year's J.P. Morgan Healthcare Conference," said Catherine Pickering, CEO and co-founder of iOnctura. "Thi...